MicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphisms

Frontiers in Molecular Neuroscience

Volumn 7, Issue JULY, 2014, Pages

  Delay, Charlotte ^a,b,c   Dorval, Véronique ^a,b   Fok, Alice ^d   Grenier Boley, Benjamin ^c   Lambert, Jean Charles ^c   Hsiung, G Y ^d   Hébert, Sébastien S ^a,b  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIV LILLE   (France)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer's disease; MicroRNA; MiR 186; MiR 455; Nicastrin; Single nucleotide polymorphism

Indexed keywords

AMYLOID BETA PROTEIN; MICRORNA; MICRORNA 186; MICRORNA 24; MICRORNA 455; NICASTRIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AGED; ALZHEIMER DISEASE; ARTICLE; BINDING SITE; BIOINFORMATICS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; SINGLE NUCLEOTIDE POLYMORPHISM; TARGET SITE POLYMORPHISM;

EID: 84904473741     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00067     Document Type: Article

References (25)

1. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355. doi: 10.1038/nature02871
2. Anonymous. (1994). Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 150, 899-913.
3. Betel, D., Wilson, M., Gabow, A., Marks, D. S., and Sander, C. (2008). The microRNA. org resource: targets and expression. Nucleic Acids Res. 36, D149-D153. doi: 10.1093/nar/gkm995
4. Chen, K., and Rajewsky, N. (2006). Natural selection on human microRNA binding sites inferred from SNP data. Nat. Genet. 38, 1452-1456. doi: 10.1038/ng1910
5. Delay, C., Calon, F., Mathews, P., and Hébert, S. S. (2011). Alzheimer-specific variants in the 3′UTR of Amyloid precursor protein affect microRNA function. Mol. Neurodegener. 6, 70. doi: 10.1186/1750-1326-6-70
6. Delay, C., Mandemakers, W., and Hébert, S. S. (2012). MicroRNAs in Alzheimer's disease. Neurobiol. Dis. 46, 285-290. doi: 10.1016/j.nbd.2012.01.003
7. De Strooper, B. (2003). Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38, 9-12. doi: 10.1016/S0896-6273(03)00205-8
8. Edbauer, D., Winkler, E., Haass, C., and Steiner, H. (2002). Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc. Natl. Acad. Sci. U.S.A. 99, 8666-8671. doi: 10.1073/pnas.132277899
9. Feldman, H., Levy, A. R., Hsiung, G.-Y., Peters, K. R., Donald, A., Black, S. E., et al. (2003). A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology22, 265-274. doi: 10.1159/000071189
10. Gamazon, E. R., Ziliak, D., Im, H. K., LaCroix, B., Park, D. S., Cox, N. J., et al. (2012). Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am. J. Hum. Genet. 90, 1046-1063. doi: 10.1016/j.ajhg.2012.04.023
11. Garcia, D. M., Baek, D., Shin, C., Bell, G. W., Grimson, A., and Bartel, D. P. (2011). Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 18, 1139-1146. doi: 10.1038/nsmb.2115
12. Glenner, G. G., and Wong, C. W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890. doi: 10.1016/S0006-291X(84)80190-4
13. Goo, J. S., Kim, Y. B., Shim, S. B., Jee, S. W., Lee, S. H., Kim, J. E., et al. (2013). Nicastrin overexpression in transgenic mice lnduces aberrant behavior and APP processing. Mol. Neurobiol. 48, 232-243. doi: 10.1007/s12035-013-8453-3
14. Hébert, S. S., Wang, W.-X., Zhu, Q., and Nelson, P. T. (2013). A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J. Alzheimers Dis. 35, 335-348. doi: 10.3233/JAD-122350
15. Hsiung, G.-Y., Sadovnick, A. D., and Feldman, H. (2004). Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 171, 863-867. doi: 10.1503/cmaj.1031789
16. Lupton, M. K., Proitsi, P., Danillidou, M., Tsolaki, M., Hamilton, G., Wroe, R., et al. (2011). Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease. PLoS ONE6:e17298. doi: 10.1371/journal.pone.0017298
17. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. doi: 10.1212/WNL.34.7.939
18. Nyabi, O., Bentahir, M., Horré, K., Herreman, A., Gottardi-Littell, N., Van Broeckhoven, C., et al. (2003). Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J. Biol. Chem. 278, 43430-43436. doi: 10.1074/jbc.M306957200
19. Pillai, R. S. (2005). MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11, 1753-1761. doi: 10.1261/rna.2248605
20. Rademakers, R., Eriksen, J. L., Baker, M., Robinson, T., Ahmed, Z., Lincoln, S. J., et al. (2008). Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 17, 3631-3642. doi: 10.1093/hmg/ddn257
21. Richardson, K., Lai, C.-Q., Parnell, L. D., Lee, Y.-C., and Ordovas, J. M. (2011). A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 12:504. doi: 10.1186/1471-2164-12-504
22. Saunders, M. A., Liang, H., and Li, W.-H. (2007). Human polymorphism at microRNAs and microRNA target sites. Proc. Natl. Acad. Sci. U.S.A. 104, 3300-3305. doi: 10.1073/pnas.0611347104
23. Thomas, L. F., Saito, T., and Sætrom, P. (2011). Inferring causative variants in microRNA target sites. Nucleic Acids Res. 39:e109. doi: 10.1093/nar/gkr414
24. Wang, G., van Der Walt, J. M., Mayhew, G., Li, Y.-J., Züchner, S., Scott, W. K., et al. (2008). Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 82, 283-289. doi: 10.1016/j.ajhg.2007.09.021
25. Yu, Z., Li, Z., Jolicoeur, N., Zhang, L., Fortin, Y., Wang, E., et al. (2007). Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 35, 4535-4541. doi: 10.1093/nar/gkm480